These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 17435868

  • 1. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
    Pietszkowski NC, Carvalho GA, Souza HN, Werka CR, Borazo LA, Graf H, Carvalho Md.
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
    [Abstract] [Full Text] [Related]

  • 2. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K, Ito K.
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [Abstract] [Full Text] [Related]

  • 3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M.
    Arthritis Res Ther; 2005 May; 7(5):R1072-81. PubMed ID: 16207324
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
    Sghiri R, Ouertani M, Ben Hsine H, Slim I, Chaieb L, Ghedira I.
    Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
    [Abstract] [Full Text] [Related]

  • 5. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K.
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M, Seki T, Ozawa H, Ishihara T, Komatsu M, Tajiri S, Yanagi H, Nishina M, Noh JY, Fukagawa M, Takagi A.
    Endocr J; 2013 Jul; 60(3):383-8. PubMed ID: 23154533
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
    Fujii A, Arimura Y, Minoshima S, Kobayashi M, Yoshihara K, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Takahashi H.
    Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566
    [Abstract] [Full Text] [Related]

  • 10. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R, Imaizumi M, Ide A, Sera N, Ueki I, Horie I, Ando T, Usa T, Ejima E, Ashizawa K, Eguchi K.
    Endocr J; 2010 Dec; 57(1):73-9. PubMed ID: 19851036
    [Abstract] [Full Text] [Related]

  • 11. [A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment].
    Shimizudani N, Senba S, Odaka T, Utsumi K, Nemoto K, Hatao H, Ito M, Adachi H, Kishi K, Oh-ishi S, Nakamura H, Matsuoka T.
    Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):98-103. PubMed ID: 19260531
    [Abstract] [Full Text] [Related]

  • 12. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody.
    Ohtsuka M, Yamashita Y, Doi M, Hasegawa S.
    Eur Respir J; 1997 Jun; 10(6):1405-7. PubMed ID: 9192950
    [Abstract] [Full Text] [Related]

  • 13. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O, Sumethkul V, Radinahmed P, Laopaiboon M, Kirdpon W.
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Myeloperoxidase-antineutrophil cytoplasmic antibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism].
    Makiyama Y, Ito M, Akiyama F, Sega H, Togashi K, Hasegawa T, Suzuki E, Arakawa M, Gejyo F.
    Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):201-5. PubMed ID: 10846402
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
    Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N.
    Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
    [Abstract] [Full Text] [Related]

  • 19. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.